[
  {
    "ts": "2025-08-05T14:30:00+00:00",
    "headline": "FBLG: Closes Third Tranche of $5M…",
    "summary": "By David Bautz, PhD NASDAQ:FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 FibroBiologics, Inc. (NASDAQ:FBLG) is continuing preparations for a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers (DFUs), which we anticipate initiating in the first quarter of",
    "url": "https://finance.yahoo.com/news/fblg-closes-third-tranche-5m-143000984.html",
    "source": "Zacks Small Cap Research",
    "provider": "yfinance",
    "raw": {
      "id": "e3380b1f-35d7-376a-977e-7db72be42c5f",
      "content": {
        "id": "e3380b1f-35d7-376a-977e-7db72be42c5f",
        "contentType": "STORY",
        "title": "FBLG: Closes Third Tranche of $5M…",
        "description": "",
        "summary": "By David Bautz, PhD NASDAQ:FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 FibroBiologics, Inc. (NASDAQ:FBLG) is continuing preparations for a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers (DFUs), which we anticipate initiating in the first quarter of",
        "pubDate": "2025-08-05T14:30:00Z",
        "displayTime": "2025-08-05T14:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/scr.zacks.com/220efefd60c66313327eac6d0deb4ba4",
          "originalWidth": 1478,
          "originalHeight": 856,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BUc4f.g_4W1K81URIsYD.Q--~B/aD04NTY7dz0xNDc4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/220efefd60c66313327eac6d0deb4ba4.cf.webp",
              "width": 1478,
              "height": 856,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OI5yPVTHn0r4MSacIMFwPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/scr.zacks.com/220efefd60c66313327eac6d0deb4ba4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks Small Cap Research",
          "url": "http://scr.zacks.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fblg-closes-third-tranche-5m-143000984.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fblg-closes-third-tranche-5m-143000984.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "FBLG"
            },
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-05T12:45:02+00:00",
    "headline": "Organon (OGN) Beats Q2 Earnings and Revenue Estimates",
    "summary": "Organon (OGN) delivered earnings and revenue surprises of +6.38% and +2.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/organon-ogn-beats-q2-earnings-124502302.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "cbeddf4b-e92a-3059-86f9-47004c007ce4",
      "content": {
        "id": "cbeddf4b-e92a-3059-86f9-47004c007ce4",
        "contentType": "STORY",
        "title": "Organon (OGN) Beats Q2 Earnings and Revenue Estimates",
        "description": "",
        "summary": "Organon (OGN) delivered earnings and revenue surprises of +6.38% and +2.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2025-08-05T12:45:02Z",
        "displayTime": "2025-08-05T12:45:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ynQsYX5ACHYPVbgtuT.Zxg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fz_9jpPkz.3eCTXvWlvRfQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/organon-ogn-beats-q2-earnings-124502302.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/organon-ogn-beats-q2-earnings-124502302.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            },
            {
              "symbol": "OGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-05T03:26:23+00:00",
    "headline": "Charles River Laboratories (CRL) Reports Earnings Tomorrow: What To Expect",
    "summary": "Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market open. Here’s what to look for.",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-crl-reports-032623266.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "25dd345c-5f3c-33a8-9e96-8dbcc37d1175",
      "content": {
        "id": "25dd345c-5f3c-33a8-9e96-8dbcc37d1175",
        "contentType": "STORY",
        "title": "Charles River Laboratories (CRL) Reports Earnings Tomorrow: What To Expect",
        "description": "",
        "summary": "Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market open. Here’s what to look for.",
        "pubDate": "2025-08-05T03:26:23Z",
        "displayTime": "2025-08-05T03:26:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CRL Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PLZRbui545u2bOcqTkunEw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YlRDliezLyxJ3r.biO59fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-crl-reports-032623266.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-crl-reports-032623266.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]